Medscape

Medscape InDiscussion: Prostate Cancer

Science EN ↓ 6 afleveringen

Listen to Medscape InDiscussion: Prostate Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988732). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Bezoek zeker de website van de podcast en steun de maker: www.medscape.com

Auteur

Medscape

Categorie

Science

Website van de podcast

www.medscape.com

Nieuwste aflevering

21 nov. 2023

Waar luisteren?

Podcasts in de app Replaio Radio Binnenkort beschikbaar

Podcasts komen binnenkort naar de app. Installeer nu en zie als eerste een compleet nieuwe kijk op podcasts

Gratis installeren Android bijna 10 mln downloads · beoordeling 4,8 iOS binnenkort

Afleveringen

Prostate Cancer and Transgender Patients: Providing Gender-Affirming Care During Screening, Diagnosis, and Treatment 21.11.2023 22:20

Drs Sandhya Srinivas and Aria F. Olumi discuss barriers to prostate cancer screening, diagnosis and treatment for transgender patients, and ways to provide gender-affirming, wraparound care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988738). The topics and discussions are planned, produced, and reviewed independently of advertis...

Which Metastatic Hormone-Sensitive Prostate Cancer Patients Are the Best Candidates for Doublet and Triplet Therapies? 24.10.2023 22:20

Drs Sandhya Srinivas and Tanya B. Dorff discuss metastatic hormone-sensitive prostate cancer, which patients are the best candidates for doublets vs triplets, and how we pick these patients. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988737). The topics and discussions are planned, produced, and reviewed independently of advertis...

New Therapies for Metastatic Castrate-Resistant Prostate Cancer: Radioligand Therapy and PSMA Biomarker-Based Imaging 21.09.2023 21:36

Drs Sandhya Srinivas and Oliver Sartor discuss the VISION study, new therapies for patients with metastatic castrate-resistant prostate cancer, and PSMA biomarker-based imaging. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988736). The topics and discussions are planned, produced, and reviewed independently of advertisers. This pod...

Germline vs Somatic Testing for Patients With Prostate Cancer: Which Patients Should Be Evaluated and When? 23.08.2023 22:42

Drs Sandhya Srinivas and Heather Cheng discuss PARP inhibitors, clinical trials, and germline vs somatic testing for patients with prostate cancer, as well as the optimal time for this testing. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988734). The topics and discussions are planned, produced, and reviewed independently of adver...

Effective Treatment Options and Sequencing for Patients With Castration-Resistant Prostate Cancer 19.07.2023 23:24

Drs Sandhya Srinivas and Shilpa Gupta discuss castration-resistant prostate cancer and the sequence, method of therapy, and specific patient populations in which these drugs will be most effective. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988733). The topics and discussions are planned, produced, and reviewed independently of a...

Androgen Deprivation Therapy and Prostate Cancer: Bone Health, Survivorship, and Side Effects 19.07.2023 21:51

Drs Sandhya Srinivas and Rana R. McKay discuss bone health and survivorship, including risk factors and potential side effects with androgen deprivation therapy in patients with prostate cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988732). The topics and discussions are planned, produced, and reviewed independently of adve...